Jana G Hashash, MD, MSc (@jhashashmd) 's Twitter Profile
Jana G Hashash, MD, MSc

@jhashashmd

Associate Professor of Medicine, GI with IBD focus @MayoClinic 🐊 | via @AUB_Lebanon 🇱🇧 @PittGIM @PittGILiverNutr

ID: 1106663313885270016

calendar_today15-03-2019 21:07:49

321 Tweet

1,1K Followers

446 Following

Saqr Alsakarneh, MD, MSc (@alsakarnehsaqr) 's Twitter Profile Photo

Have you ever thought about the effect of #Frailty on inpatient outcomes of patients with IBD? 🤓 In this first of its kind 🌟 study we found that: 📌Frail individuals with IBD are at higher risk of mortality 🪦 (aOR=9) 📌Higher sepsis (aOR=27) and AKI (8.9) 📌Frail patients

Have you ever thought about the effect of #Frailty on inpatient outcomes of patients with IBD? 🤓

In this first of its kind 🌟 study we found that: 
📌Frail individuals with IBD are at higher risk of mortality 🪦 (aOR=9)
📌Higher sepsis (aOR=27) and AKI (8.9)
📌Frail patients
GI & Hepatology News (@aga_gihn) 's Twitter Profile Photo

Our latest quarterly Perspectives column tackles the issue of GLP-1 receptor agonists in GI endoscopy. Jana G Hashash, MD, MSc offers the gastroenterologist viewpoint while Drs. Thomas Hickey and Ryan Pouliot discuss from an anesthesiologist's POV. ow.ly/Csxx50SyjBP

Our latest quarterly Perspectives column tackles the issue of GLP-1 receptor agonists in GI endoscopy. <a href="/JHashashMD/">Jana G Hashash, MD, MSc</a> offers the gastroenterologist viewpoint while Drs. Thomas Hickey and Ryan Pouliot discuss from an anesthesiologist's POV. ow.ly/Csxx50SyjBP
Jordan Axelrad, MD, MPH (@drjordanaxelrad) 's Twitter Profile Photo

(1) 📢 New American Gastroenterological Association (AGA) Clinical Practice Update on Management of #IBD in Patients With #Malignancy 📢 cghjournal.org/article/S1542-… 🔥🔥An #IBD tweetorial on #Cancer for #GITwitter from Jordan Axelrad, MD, MPH, Jana G Hashash, MD, MSc, #StevenItzkowitz and published in CGH🔥🔥 Follow this🧵

PSC Partners Seeking a Cure (@pscpartners) 's Twitter Profile Photo

For more information about the 2024 PSC Partners 20th Anniversary Annual Conference, and to register, click here: bit.ly/2024PSCPAnnual… #PSCaware #PSCPartners2024 #livertwitter

For more information about the 2024 PSC Partners 20th Anniversary Annual Conference, and to register, click here: bit.ly/2024PSCPAnnual…

#PSCaware #PSCPartners2024 #livertwitter
Mayo Clinic Gastroenterology & Hepatology (@mayoclinicgihep) 's Twitter Profile Photo

Congratulations to Nayantara Coelho for being re-elected as the ACG Minnesota Governor! Her knowledge for #IBD research, care, and procedures is expansive and we are proud to see you back in the Governors chair!

Congratulations to <a href="/NayantaraCoelho/">Nayantara Coelho</a> for being re-elected as the ACG Minnesota Governor! Her knowledge for #IBD research, care, and procedures is expansive and we are proud to see you back in the Governors chair!
Philip Okafor (@philipokaformd) 's Twitter Profile Photo

Do you care for inpatients with GI or liver diseases? Then join us for the 2nd Annual Mayo Clinic Gastroenterology for the Hospital Provider 2025 in Nashville from February 22, 2025 to February 23, 2025 ce.mayo.edu/gastro2025 #cme #gi #liver #medicine #hospitalist #mayoclinic

Do you care for inpatients with GI or liver diseases? Then join us for the 2nd Annual Mayo Clinic Gastroenterology for the Hospital Provider 2025 in Nashville from February 22, 2025 to February 23, 2025 ce.mayo.edu/gastro2025

#cme #gi #liver #medicine #hospitalist #mayoclinic
Wissam Ghusn (@wissam_ghusn) 's Twitter Profile Photo

🔴 New Publication: Immunomodulators, Biologic Therapies, and Small Molecules in IBD and solid organ transplants ▪️ Assess safety of IBD therapies with immunosuppressants ▪️ Liver, Renal, and Heart transplants pubmed.ncbi.nlm.nih.gov/39145836/ Jana G Hashash, MD, MSc Francis (Frank) Farraye, MD, MSc Shabana Pasha, M.D.

🔴 New Publication: Immunomodulators, Biologic Therapies, and Small Molecules in IBD and solid organ transplants

▪️ Assess safety of IBD therapies with immunosuppressants   
▪️ Liver, Renal, and Heart transplants

pubmed.ncbi.nlm.nih.gov/39145836/

<a href="/JHashashMD/">Jana G Hashash, MD, MSc</a> <a href="/FarrayeIBD/">Francis (Frank) Farraye, MD, MSc</a> <a href="/PashaShabanaMD/">Shabana Pasha, M.D.</a>
Saqr Alsakarneh, MD, MSc (@alsakarnehsaqr) 's Twitter Profile Photo

#IBD burden series 2️⃣ In this paper we discuss the recent changes in the epidemiology of #IBD in the #MENA region 🌍 This paper means a lot to me! We were able to objectively identify #disparities in a region where objective data 📊 is too little 😥 Thankful to the guidance

#IBD burden series 2️⃣ 

In this paper we discuss the recent changes in the epidemiology of #IBD in the #MENA region 🌍 

This paper means a lot to me! We were able to objectively identify #disparities in a region where objective data 📊 is too little 😥 

Thankful to the guidance
American Gastroenterological Association (AGA) (@amergastroassn) 's Twitter Profile Photo

⏰This is your final call to submit clinical guideline and clinical practice update topics for consideration! The deadline is tomorrow, Sept. 5! Follow the steps here: ow.ly/b6vW50T43b1

Jana G Hashash, MD, MSc (@jhashashmd) 's Twitter Profile Photo

🔊 Do you have a clinical question where more guidance is needed? There’s a call for topics for American Gastroenterological Association (AGA) Clinical Practice Updates (CPUs) for pub consideration in Gastroenterology or CGH Topic suggestion form @ surveymonkey.com/r/VZM8WFN or email [email protected]

🔊 Do you have a clinical question where more guidance is needed?

There’s a call for topics for <a href="/AmerGastroAssn/">American Gastroenterological Association (AGA)</a> Clinical Practice Updates (CPUs) for pub consideration in <a href="/AGA_Gastro/">Gastroenterology</a> or <a href="/AGA_CGH/">CGH</a>

Topic suggestion form @ surveymonkey.com/r/VZM8WFN
or email clinicalpractice@gastro.org
Fouad Jaber, MD, MS (@fouadsjaber) 's Twitter Profile Photo

🚨New Publication 🚨 Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials ⚡️In 5 trials involving 1120 patients with moderate to severe UC, targeting IL-23 showed:

🚨New Publication 🚨

Efficacy and Safety of Interleukin-12/23 and Interleukin-23 Inhibitors for Ulcerative Colitis: A Systematic Review Ad Meta-Analysis of Randomized Controlled Trials

⚡️In 5 trials involving 1120 patients with moderate to severe UC, targeting IL-23 showed:
Nabeeha Mohy-ud-din MD (@nabeehamohyudd1) 's Twitter Profile Photo

All the non-educational reasons I love AHN Gastroenterology, Hepatology and Nutrition IBD summit ⭐️ Love learning from and supporting the the inspiring IBD women Sandra El-Hachem and team ⭐️ Great food throughout the day ⭐️ Always in a great location in nice weather ☀️ & ofcourse a brilliant line up of speakers

All the non-educational reasons I love <a href="/AHNGastro/">AHN Gastroenterology, Hepatology and Nutrition</a> IBD summit

⭐️ Love learning from and supporting the the inspiring IBD women <a href="/SandraElHachem2/">Sandra El-Hachem</a> and team
⭐️ Great food throughout the day
⭐️ Always in a great location in nice weather ☀️ 

&amp;  ofcourse a brilliant line up of speakers